Featured2 years ago
Trevena (NASDAQ: TRVN): A Biotech Low Float Runner
Trevena (NASDAQ: TRVN) announced that its partner, Jiangsu Nhwa, has received approval from China’s National Medical Products Administration (NMPA) for its opioid pain medication, Olinvyk. The...